The ITGAL gene helps white blood cells stick to other cells and move to places where your body needs an immune response. If it does not work properly, these cells may struggle to reach and attach where needed, which can lead to repeated infections and problems with normal inflammation. Many variants are harmless, while a few may change how the gene supports immune cell communication. Researchers also study the ITGAL gene because changes in this pathway may play a role in some autoimmune conditions.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, which are the working parts of cells. Other genes mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ITGALGene function
What if the gene works
The ITGAL gene helps make a protein on white blood cells that lets them stick to other cells and move where they are needed. This supports immune cell communication and the body’s defense against infection.
Risk
What if the gene does not work
More disruptive variants in the ITGAL gene can cause a leukocyte adhesion deficiency-like immune condition, with recurrent infections, gum disease, and slow wound healing. Milder variants may leave some protein function, so symptoms can appear later or be less severe.
Treatment
What does that mean for your treatment
No ITGAL-specific treatment or management approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the ITGAL gene. The ITGAL gene is being studied as an immune system biomarker and drug target in inflammatory conditions and cancer, but this has not led to guideline-based treatment decisions for ITGAL-related care.
Gene function
What if the gene works
Your immune cells need to travel, stop, and connect with other cells at the right time. The ITGAL gene helps make part of a surface protein on white blood cells that supports those steps. When it is working normally, immune cells can grip, move, and exchange signals in a controlled way.
The ITGAL gene helps white blood cells stick to blood vessel walls and to other immune cells. This controlled attachment lets them slow down, stop in the right place, and make close contact when needed.
By helping cells grip and release in sequence, this gene supports normal immune cell movement from the bloodstream into tissues. That allows routine immune patrol and a timely response where germs or injury are present.
ITGAL also helps T cells form a stable contact area with other cells while they check for signs of infection. This close connection supports clear signal exchange and more organized immune activation.
Some immune cells use this same surface grip to hold onto cells they need to examine or remove. That firm but controlled contact helps the immune response stay focused on the right target.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ITGAL gene can change the shape of the CD11a cell surface protein, reduce how much of it reaches the cell membrane, or weaken its binding to CD18. In practice, this is how ITGAL gene variants affect cell adhesion and signaling between immune cells. Milder variants may leave some protein activity, while more severe variants can greatly reduce stability or block normal protein pairing, leading to a larger loss of function.
How variants are linked to conditions
Research on how ITGAL gene variants are linked to conditions is still developing, and there is not yet a broadly confirmed connection to one specific health condition. Anyone with a confirmed ITGAL-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ITGAL gene. Personal risk, if an ITGAL change is found, often depends more on the exact gene change and the health condition involved than on lifestyle or environmental factors.
Inheritance of ITGAL variants
For families trying to understand how ITGAL gene variants are inherited, there is not yet a broadly confirmed Mendelian inheritance pattern tied to one specific ITGAL related condition. Most findings involving the ITGAL gene are discussed as risk influences rather than a clear-cut inherited syndrome with a single dominant or recessive pattern. The ITGAL gene is located on chromosome 16, which is an autosome, so you inherit one copy from each parent. This means any inherited ITGAL variant can be passed through either side of the family.
What does my ITGAL result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for ITGAL, though this can become clearer as research grows. If you have a specific ITGAL result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help explain it in the context of your family.
Genetic information
Genetic testing
How you find out about variants
ITGAL variants are found through genetic testing, usually using DNA from blood or saliva. An ITGAL genetic test reads the ITGAL gene and compares it with a reference sequence to identify benign variants, uncertain findings, or pathogenic variants.
When should I consider getting a genetic test?
There is not yet a broadly established, ITGAL-specific reason for genetic testing in routine care. Decisions about testing are usually based on your symptoms, medical history, and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, has little effect in another, or causes more side effects in someone else. These differences are common and are one part of the reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way medications work. By studying links between genes and specific drugs, it helps explain why the same treatment may not have the same effect in every person. For many medicines, genes influence how the body handles a drug or how much effect it has. This information can support more personalized and informed treatment choices. More detail on this topic is available in the LearnHub.
Drugs influenced by the ITGAL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
ITGAL entered medical research through studies of white blood cell surface proteins in the late 1970s, when scientists identified leukocyte function associated antigen 1, or LFA-1, as a key player in immune cell interactions. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect cell biology with human genetics. In the 1980s, researchers linked the protein’s alpha chain to the ITGAL gene and mapped it to chromosome 16. From these first observations, research expanded steadily, especially in immunology, transplantation, and inflammatory disease. That history made ITGAL part of the broader story of how scientists learned that cell adhesion molecules shape immune responses and can become targets for treatment.